Medscape: HRT Tied to Increased Risk of Severe Asthma Exacerbation
UC allergist discusses hormone replacement therapy’s impact on asthmatic women
Jonathan Bernstein, MD, allergist and professor in the University of Cincinnati College of Medicine, weighs in on a study that suggests hormone replacement therapy may increase the risk of severe asthma in peri- and post-menopausal women.
Researchers say that starting around puberty, asthma becomes more common and severe in women than in men and that continues in women until around menopause. Sex hormones may partly explain the difference.
"It is clear that some women have worsening of a number of health issues peri-menstrual when there are estrogen and/or progesterone surges, including asthma, migraines, urticaria and hereditary angioedema, among other conditions,” Bernstein told a Reuters Health journalist for a story that appeared in Medscape.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.